William Hyman

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735

Stephen E. Jones, Frankie A. Holmes, Joyce O’Shaughnessy et al. · Journal of Clinical Oncology · 2009 · 586 citations

Medicine, Oncology, Pharmacology +11

Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer

Stephen E. Jones, Michael A. Savin, Frankie A. Holmes et al. · Journal of Clinical Oncology · 2006 · 540 citations · Full text

Medicine, Oncology, Pharmacology +17

A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia

Craig H. Reynolds, Nicholas Di Bella, Roger M. Lyons et al. · Investigational New Drugs · 2011 · 63 citations

Medicine, Immunology, Oncology +14

Cellular Immune Profile of Patients With Advanced Cancer Before and After Taxane Treatment

A W Tong, Bryan Seamour, Jennifer Lawson et al. · American Journal of Clinical Oncology · 2000 · 54 citations

Medicine, Immunology, Oncology +17

Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab Vs. Pentostatin, Cyclophosphamide, and Rituximab in B-Cell Chronic Lymphocytic Leukemia

Craig H. Reynolds, Nicholas Di Bella, Roger M. Lyons et al. · Blood · 2008 · 28 citations

Medicine, Oncology, Pharmacotherapy +15